Comparing UroLift Experience Against Rezum (C.L.E.A.R. Study)

Go Back to All Clinical Trials

Comparing UroLift Experience Against Rezum (C.L.E.A.R. Study)

Brief description of study

The purpose of this study is to compare two different minimally invasive procedures often used to treat the symptoms of benign prostatic hyperplasia (BPH): the UroLiftTM System procedure and the RezumTM System procedure. Both of these are FDA-approved.

Clinical Study Identifier: s20-01235

Principal Investigator: Jeffrey Todd Schiff.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies